T 1133/18 (Sublingual apomorphine/SUNOVION) of 15.12.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T113318.20211215
- Date of decision
- 15 December 2021
- Case number
- T 1133/18
- Online on
- 26 January 2022
- Petition for review of
- -
- Application number
- 10786915.8
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- SUBLINGUAL APOMORPHINE
- Applicant name
- Sunovion Pharmaceuticals Inc.
- Opponent name
- Generics (U.K.) Limited
LTS LOHMANN Therapie-Systeme AG - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 83European Patent Convention Art 56
- Keywords
- Amendments - allowable (yes)
Sufficiency of disclosure - (yes)
Inventive step - (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
- The decision is set aside.
- The case is remitted to the opposition division with the order to maintain the patent on the basis of the following documents:
(i) claim 1 to claim 13 of the main request (filed as auxiliary 2 with the reply to the grounds of appeal)
(ii) a description possibly to be adapted thereto.